Report Type: Industry Trends
Report Category: Regulatory Insights
Report Subcategory: 505 (b)2 Drugs
Price: 2999.00
Date: July 2021

505 (B) 2 Pathway: Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

505 (b)(2) Pathway:
The 505 (b)(2) pathway provides manufacturers who have certain types of drugs with an opportunity to acquire FDA approval without performing all the work that’s required with an NDA. These drugs are not strictly generics, but are often not entirely novel new molecular entities either. 505 (b)(2) can be an option for drugs with a new aspect related to indication, dosage form or regimen, strength, combination with other products, or other unique traits.